Home > Insider Trading > Filing (0001181431-11-009235)

Filing Details

Accession Number:: 0001181431-11-009235
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-02-10 20:06:52
Reporting Period:: 2011-02-08

Filing Date:: 2011-02-10
Accepted Time:: 2011-02-10 20:06:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1396814	Pacira Pharmaceuticals Inc.	PCRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1267959	A Fred Middleton	C/O Sanderling Ventures 400 South El Camino Real, Suite 1200 San Mateo CA 94402		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-02-08	736,583	$0.00	736,583	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2011-02-08	14,877	$0.00	14,877	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2011-02-08	24,871	$0.00	24,871	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2011-02-08	29,634	$0.00	29,634	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2011-02-08	681,715	$0.00	681,715	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2011-02-08	344,355	$0.00	344,355	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2011-02-08	12,058	$0.00	12,058	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2011-02-08	14,366	$0.00	14,366	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2011-02-08	341,788	$0.00	341,788	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2011-02-08	129,445	$0.00	129,445	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2011-02-08	4,533	$0.00	4,533	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2011-02-08	5,400	$0.00	5,400	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2011-02-08	128,479	$0.00	128,479	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2011-02-08	46,379	$7.00	46,379	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2011-02-08	27,931	$7.00	27,931	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2011-02-08	4,297	$7.00	4,297	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2011-02-08	5,119	$7.00	5,119	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2011-02-08	184,131	$7.00	184,131	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2011-02-08	736,583	$0.00	736,583	$0.00
Common Stock	Series A Convertible Preferred Stock	Disposition	2011-02-08	14,877	$0.00	14,877	$0.00
Common Stock	Series A Convertible Preferred Stock	Disposition	2011-02-08	24,871	$0.00	24,871	$0.00
Common Stock	Series A Convertible Preferred Stock	Disposition	2011-02-08	29,634	$0.00	29,634	$0.00
Common Stock	Series A Convertible Preferred Stock	Disposition	2011-02-08	681,715	$0.00	681,715	$0.00
Common Stock	Convertible Promissory Notes	Disposition	2011-02-08	344,355	$0.00	344,355	$0.00
Common Stock	Convertible Promissory Notes	Disposition	2011-02-08	12,058	$0.00	12,058	$0.00
Common Stock	Convertible Promissory Notes	Disposition	2011-02-08	14,366	$0.00	14,366	$0.00
Common Stock	Convertible Promissory Notes	Disposition	2011-02-08	341,788	$0.00	341,788	$0.00
Common Stock	Convertible Promissory Notes	Disposition	2011-02-08	129,445	$0.00	129,445	$0.00
Common Stock	Convertible Promissory Notes	Disposition	2011-02-08	4,533	$0.00	4,533	$0.00
Common Stock	Convertible Promissory Notes	Disposition	2011-02-08	5,400	$0.00	5,400	$0.00
Common Stock	Convertible Promissory Notes	Disposition	2011-02-08	128,479	$0.00	128,479	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

The securities are held by Sanderling Venture Partners VI, L.P. Mr. Middleton is a managing director of Middleton, McNeil, Mills & Associates VI, LLC, which has the ultimate voting and investment power over shares held of record by Sanderling Venture Partners VI, L.P., and he may be deemed to have voting and investment power over shares held of record by Sanderling Venture Partners VI, L.P. Mr. Middleton disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein.
The securities are held by Sanderling Ventures Management VI. Mr. Middleton is the owner of Sanderling Ventures Management VI and he may be deemed to have voting and investment power over shares held of record by Sanderling Ventures Management VI. Mr. Middleton disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein.
The securities are held by Sanderling VI Beteiligungs GmbH & Co. KG. Mr. Middleton is a managing director of Middleton, McNeil, Mills & Associates VI, LLC, which has the ultimate voting and investment power over shares held of record by Sanderling VI Beteiligungs GmbH & Co. KG, and he may be deemed to have voting and investment power over shares held of record by Sanderling VI Beteiligungs GmbH & Co. KG. Mr. Middleton disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein.
The securities are held by Sanderling VI Limited Partnership. Mr. Middleton is a managing director of Middleton, McNeil, Mills & Associates VI, LLC, which has the ultimate voting and investment power over shares held of record by Sanderling VI Limited Partnership, and he may be deemed to have voting and investment power over shares held of record by Sanderling VI Limited Partnership. Mr. Middleton disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein.
The Series A Convertible Preferred Stock had no expiration date and each share of Series A Convertible Preferred Stock was automatically converted into common stock on a 1-for-1 basis upon the consummation of the Issuer's initial public offering.
The securities are held by Sanderling Venture Partners VI Co-Investment Fund. Mr. Middleton is a managing director of Middleton, McNeil, Mills & Associates VI, LLC, which has the ultimate voting and investment power over shares held of record by Sanderling Venture Partners VI Co-Investment Fund, and he may be deemed to have voting and investment power over shares held of record by Sanderling Venture Partners VI Co-Investment Fund. Mr. Middleton disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein.
All principal and accrued interest on the Convertible Promissory Notes was automatically converted into shares of Common Stock upon the consummation of the Issuer's initial public offering.
All principal on the Convertible Promissory Notes was automatically converted into shares of Common Stock upon the consummation of the Issuer's initial public offering at a conversion price equal to the per share price of the Common Stock sold in the Issuer's initial public offering.